Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rite Aid Sales Slow With OTC Claritin, HRT Slump; Growing Rx Count Is Focus

Executive Summary

Rite Aid is attributing its slower growth in prescription drug sales to reduced hormone therapy demand and the Claritin OTC switch

You may also be interested in...



Rite Aid Eyes Eckerd Customers During Transition; Profits Recovering

Rite Aid believes its new drug distribution contract with McKesson will bolster the chain's turnaround heading into fiscal 2005

Rite Aid Eyes Eckerd Customers During Transition; Profits Recovering

Rite Aid believes its new drug distribution contract with McKesson will bolster the chain's turnaround heading into fiscal 2005

Rx Market Starts Slow In 2003; IMS Still Confident Of Double-Digit Growth

IMS Health remains confident that the overall pharmaceutical market will grow in the double digits during 2003 despite the market's slow start

Related Content

UsernamePublicRestriction

Register

LL1135415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel